04/16/2024
3:15 PM | Onconova Therapeutics (Filer)
Traws Pharma, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
04/12/2024
3:11 PM | ORBIMED ADVISORS LLC (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
| Form 3/A | |
04/11/2024
4:41 PM | TPAV, LLC (Reporting)
Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
| Form 3/A | |
04/08/2024
8:37 PM | Onconova Therapeutics (Subject)
Traws Pharma, Inc. (Subject)
Viriom, Inc. (Filed by)
| Form SC 13D | |
04/03/2024
7:01 PM | Savchuk Nikolay (Reporting)
Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:03 PM | CAUTREELS WERNER (Reporting)
Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:04 PM | Pauza Charles David (Reporting)
Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/03/2024
7:07 PM | Redfield Robert (Reporting)
Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:50 PM | Savchuk Nikolay (Reporting)
Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:51 PM | TPAV, LLC (Reporting)
Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:53 PM | CAUTREELS WERNER (Reporting)
Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:54 PM | Pauza Charles David (Reporting)
Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:55 PM | Redfield Robert (Reporting)
Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:56 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:57 PM | Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
Viriom, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
6:59 PM | Dukes Iain D. (Reporting)
Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:47 PM | Dukes Iain D. (Reporting)
Onconova Therapeutics (Issuer)
Traws Pharma, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/15/2024
4:36 PM | Fruchtman Steven M (Reporting)
Onconova Therapeutics (Issuer)
Onconova Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:40 PM | Guerin Mark Patrick (Reporting)
Onconova Therapeutics (Issuer)
Onconova Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
3:48 PM | Fruchtman Steven M (Reporting)
Onconova Therapeutics (Subject)
Onconova Therapeutics, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024
3:49 PM | Guerin Mark Patrick (Reporting)
Onconova Therapeutics (Subject)
Onconova Therapeutics, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
4:36 PM | Fruchtman Steven M (Reporting)
Onconova Therapeutics (Issuer)
Onconova Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
4:38 PM | Guerin Mark Patrick (Reporting)
Onconova Therapeutics (Issuer)
Onconova Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:09 PM | Fruchtman Steven M (Reporting)
Onconova Therapeutics (Subject)
Onconova Therapeutics, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/27/2023
3:35 PM | Moyo Victor M (Reporting)
Onconova Therapeutics (Issuer)
Onconova Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/27/2023
3:41 PM | Moyo Victor M (Reporting)
Onconova Therapeutics (Issuer)
Onconova Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
4:00 PM | Onconova Therapeutics (Filer)
Onconova Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
4:52 PM | Onconova Therapeutics (Issuer)
Onconova Therapeutics, Inc. (Issuer)
STOVER JACK E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
4:53 PM | Onconova Therapeutics (Issuer)
Onconova Therapeutics, Inc. (Issuer)
Shoemaker Mary Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
4:41 PM | MARINO JAMES J (Reporting)
Onconova Therapeutics (Issuer)
Onconova Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
4:43 PM | GROOPMAN JEROME (Reporting)
Onconova Therapeutics (Issuer)
Onconova Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
4:45 PM | MEHTA VIREN (Reporting)
Onconova Therapeutics (Issuer)
Onconova Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
4:47 PM | Clarke Trafford (Reporting)
Onconova Therapeutics (Issuer)
Onconova Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
4:49 PM | Atadja Peter (Reporting)
Onconova Therapeutics (Issuer)
Onconova Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
4:28 PM | Onconova Therapeutics (Filer)
Onconova Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
4:18 PM | Onconova Therapeutics (Filer)
Onconova Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2023
3:42 PM | Fruchtman Steven M (Reporting)
Onconova Therapeutics (Issuer)
Onconova Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2023
3:45 PM | Guerin Mark Patrick (Reporting)
Onconova Therapeutics (Issuer)
Onconova Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
3:45 PM | Onconova Therapeutics (Filer)
Onconova Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2023
3:50 PM | Onconova Therapeutics (Filer)
Onconova Therapeutics, Inc. (Filer)
| Form DEFA14A | |
07/11/2023
11:15 PM | Onconova Therapeutics (Filer)
Onconova Therapeutics, Inc. (Filer)
| Form EFFECT | |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
06/30/2023
3:46 PM | Onconova Therapeutics (Filer)
Onconova Therapeutics, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/07/2023
3:30 PM | Onconova Therapeutics (Filer)
Onconova Therapeutics, Inc. (Filer)
| Form DEF 14A | |
06/07/2023
3:35 PM | Onconova Therapeutics (Filer)
Onconova Therapeutics, Inc. (Filer)
| Form ARS | |
05/15/2023
4:19 PM | Onconova Therapeutics (Filer)
Onconova Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
4:21 PM | Onconova Therapeutics (Filer)
Onconova Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
7:35 AM | Onconova Therapeutics (Filer)
Onconova Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2023
3:32 PM | Onconova Therapeutics (Filer)
Onconova Therapeutics, Inc. (Filer)
| Form 10-K/A | |
